Literature DB >> 1287926

Cryptosporidium: different behaviour in calves of isolates of human origin.

E Pozio1, M A Gomez Morales, F M Barbieri, G La Rosa.   

Abstract

The behaviour in calves of 3 Cryptosporidium human isolates was analysed in comparison with a bovine isolate. Twenty-four neonatal calves were infected. An isolate from a patient infected with human immunodeficiency virus (HIV) and showing mild cryptosporidiosis caused severe diarrhoea with a high production of oocysts in neonatal calves, as did a bovine isolate (group 1). Two human isolates, obtained from HIV patients with severe cryptosporidiosis, caused mild diarrhoea with low oocyst production in neonatal calves (group 2). The difference between the 2 groups in numbers of oocysts shed in calves was statistically significant (P = 0.005), as was the duration of oocyst shedding (P = 0.0004). Oocysts of group 2 isolates were less resistant to storage in 2% potassium dichromate at 4 degrees C than were oocysts of group 1. The biological and epidemiological implications are discussed.

Entities:  

Mesh:

Year:  1992        PMID: 1287926     DOI: 10.1016/0035-9203(92)90165-9

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  10 in total

Review 1.  Genomics and population biology of Cryptosporidium species.

Authors:  G Widmer; S Sullivan
Journal:  Parasite Immunol       Date:  2012 Feb-Mar       Impact factor: 2.280

Review 2.  New insights into human cryptosporidiosis.

Authors:  D P Clark
Journal:  Clin Microbiol Rev       Date:  1999-10       Impact factor: 26.132

3.  Evaluation of high-dose regimen of paromomycin against cryptosporidiosis in the dexamethasone-treated rat model.

Authors:  R Verdon; J Polianski; C Gaudebout; C Marche; L Garry; C Carbon; J J Pocidalo
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

4.  Characterization and immunolocalization of a Cryptosporidium protein containing repeated amino acid motifs.

Authors:  L Ranucci; H M Müller; G La Rosa; I Reckmann; M A Morales; F Spano; E Pozio; A Crisanti
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

5.  Evaluation of an animal model system for cryptosporidiosis: therapeutic efficacy of paromomycin and hyperimmune bovine colostrum-immunoglobulin.

Authors:  S Tzipori; W Rand; J Griffiths; G Widmer; J Crabb
Journal:  Clin Diagn Lab Immunol       Date:  1994-07

6.  Multilocus genotypic analysis of Cryptosporidium parvum isolates from different hosts and geographical origins.

Authors:  F Spano; L Putignani; A Crisanti; P Sallicandro; U M Morgan; S M Le Blancq; L Tchack; S Tzipori; G Widmer
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

Review 7.  Genetic polymorphism among Cryptosporidium parvum isolates: evidence of two distinct human transmission cycles.

Authors:  M M Peng; L Xiao; A R Freeman; M J Arrowood; A A Escalante; A C Weltman; C S Ong; W R Mac Kenzie; A A Lal; C B Beard
Journal:  Emerg Infect Dis       Date:  1997 Oct-Dec       Impact factor: 6.883

8.  Integration of halofuginone lactate treatment and disinfection with p-chloro-m-cresol to control natural cryptosporidiosis in calves.

Authors:  Judith Keidel; Arwid Daugschies
Journal:  Vet Parasitol       Date:  2013-03-14       Impact factor: 2.738

9.  Pathogenicity of Cryptosporidium parvum--evaluation of an animal infection model.

Authors:  H L Enemark; V Bille-Hansen; P Lind; P M H Heegaard; H Vigre; P Ahrens; S M Thamsborg
Journal:  Vet Parasitol       Date:  2003-04-02       Impact factor: 2.738

10.  Enterotoxic effect of stool supernatant of Cryptosporidium-infected calves on human jejunum.

Authors:  A Guarino; R B Canani; E Pozio; L Terracciano; F Albano; M Mazzeo
Journal:  Gastroenterology       Date:  1994-01       Impact factor: 22.682

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.